Net Income

The Chinese auto-tech firm regained Nasdaq's minimum bid price but still faces delisting over its low market value, setting up a critical hearing.

A major credit upgrade for CABEI reflects a year of smart financial maneuvering, promising cheaper funding for Central America's development projects.

With drug costs soaring, industry veteran Ritu Malhotra joins Illuminate Rx, promising to disrupt the opaque PBM market. But can transparency truly win?

A new report reveals a paradoxical trend: plaintiff firms are filing fewer securities lawsuits but securing record-breaking, multi-million dollar settlements.

Eason Technology is betting its future on Chinese real estate with a deal that could dilute shareholders by over 80%. But can it get past the NYSE?

With final approval for its C$3.3 billion acquisition by GTCR, Dentalcorp's move to private ownership is set to reshape Canada's dental landscape.

With three international awards, Marina Pointe isn't just selling condos; it's cementing Tampa Bay's status as a premier global luxury destination.

CN moved record volumes of Canadian grain in 2025, fueled by a historic harvest. This article dives into the logistics, challenges, and competition.

Promising Phase 2 data shows a new DNA immunotherapy for advanced melanoma, delivered via a needle-free jet injector, significantly improves patient outcomes.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

A joint venture of Elliott and Morning Calm has acquired City Office REIT, a bold move signaling a contrarian belief in the office market's recovery.

As Westwood One airs its 39th straight NFL playoffs, its strategy blends classic radio with digital reach, proving audio's lasting power in sports.

As Telus offers nearly 700 severance packages, unions warn of declining service quality, while data reveals a company grappling with cost pressures.

A new alliance aims to advance KFRX06, a unique Parkinson's therapy that goes beyond a single target to potentially offer a more comprehensive treatment.

A new $50M venture fund from Penn, BioNTech, and OUP aims to turn the university's breakthrough research into life-saving therapies faster than ever.

Meta's historic nuclear energy purchase signals a major shift in Big Tech's strategy to meet soaring AI power demands and reshape the US energy grid.

A new platform promises high daily returns for XRP investors by linking crypto to renewable energy, but a closer look reveals significant red flags.

Maria Montenegro, an AI and M&A expert, takes the helm of the CP & ESG unit, signaling a major push into tech-driven corporate compliance and performance.

After resolving manufacturing hurdles, Camurus' self-administered acromegaly treatment Oclaiz is back on track for US approval, promising new hope for patients.

The value furniture giant is going public, revealing strong growth and ambitious expansion plans. Can its "Everyday Low Prices" model win over Wall Street?